Dexchlorpheniramine
- Generic Name
- Dexchlorpheniramine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C16H19ClN2
- CAS Number
- 25523-97-1
- Unique Ingredient Identifier
- 3Q9Q0B929N
- Background
Dexchlorpheniramine is a potent S-enantiomer of chlorpheniramine. The salt form dexchlorpheniramine maleate as the active ingredient is available as a prescription drug indicated for adjunctive therapy for allergic and anaphylactic reactions. It is an antihistamine drug with anticholinergic (drying) and sedative actions. It disrupts histamine signaling by co...
- Associated Conditions
- Allergy to Tree Pollen, Common Cold, Conjunctivitis, Dermatitis, Insect Bites, Pruritus, Rhinitis, Sunburn, Urticaria, Vasomotor Rhinitis
- Associated Therapies
- -
A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2017-12-11
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Genzyme, a Sanofi Company
- Target Recruit Count
- 16
- Registration Number
- NCT03368664
- Locations
- 🇹🇷
Investigational Site Number :7920002, Ankara, Turkey
🇹🇷Investigational Site Number :7920001, Ankara, Turkey
🇫🇷Investigational Site Number :2500002, Strasbourg, France
A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis
- First Posted Date
- 2015-10-22
- Last Posted Date
- 2021-03-10
- Lead Sponsor
- Genzyme, a Sanofi Company
- Target Recruit Count
- 24
- Registration Number
- NCT02583594
- Locations
- 🇪🇸
Investigational Site Number 724001, Barcelona, Spain
Comparison Between Dexchlorpheniramine and Dexchlorpheniramine/Pseudoephedrine/Guaifenesin in Respiratory Infections
- First Posted Date
- 2010-03-12
- Last Posted Date
- 2010-03-12
- Lead Sponsor
- Mantecorp Industria Quimica e Farmaceutica Ltd.
- Target Recruit Count
- 170
- Registration Number
- NCT01085721
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath